Entering text into the input field will update the search result below

Turning Point Therapeutics falls as science chief resigns

Mar. 04, 2022 4:39 PM ETBristol-Myers Squibb Company (BMY)By: Dulan Lokuwithana, SA News Editor1 Comment

Text Resignation is written on wooden building blocks lying on an office desk. Business concept.n letter to his boss, change of job, unemployment, resign concept.

Vadzim Kushniarou/iStock via Getty Images

  • The shares of clinical-stage biotech, Turning Point Therapeutics (NASDAQ:TPTX), is trading ~6% lower on Friday after the precision oncology company announced the resignation of its Executive Vice President and Chief Scientific Officer, Siegfried Reich.
  • On Feb. 28, Dr. Reich

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.